Correlation Between Tarsus Pharmaceuticals and Irkutsk Public

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tarsus Pharmaceuticals and Irkutsk Public at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tarsus Pharmaceuticals and Irkutsk Public into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tarsus Pharmaceuticals and Irkutsk Public Joint, you can compare the effects of market volatilities on Tarsus Pharmaceuticals and Irkutsk Public and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tarsus Pharmaceuticals with a short position of Irkutsk Public. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tarsus Pharmaceuticals and Irkutsk Public.

Diversification Opportunities for Tarsus Pharmaceuticals and Irkutsk Public

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Tarsus and Irkutsk is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Tarsus Pharmaceuticals and Irkutsk Public Joint in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Irkutsk Public Joint and Tarsus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tarsus Pharmaceuticals are associated (or correlated) with Irkutsk Public. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Irkutsk Public Joint has no effect on the direction of Tarsus Pharmaceuticals i.e., Tarsus Pharmaceuticals and Irkutsk Public go up and down completely randomly.

Pair Corralation between Tarsus Pharmaceuticals and Irkutsk Public

If you would invest  4,757  in Tarsus Pharmaceuticals on September 13, 2024 and sell it today you would earn a total of  457.00  from holding Tarsus Pharmaceuticals or generate 9.61% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Tarsus Pharmaceuticals  vs.  Irkutsk Public Joint

 Performance 
       Timeline  
Tarsus Pharmaceuticals 

Risk-Adjusted Performance

20 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Tarsus Pharmaceuticals are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Tarsus Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.
Irkutsk Public Joint 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Irkutsk Public Joint has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong technical and fundamental indicators, Irkutsk Public is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Tarsus Pharmaceuticals and Irkutsk Public Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Tarsus Pharmaceuticals and Irkutsk Public

The main advantage of trading using opposite Tarsus Pharmaceuticals and Irkutsk Public positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tarsus Pharmaceuticals position performs unexpectedly, Irkutsk Public can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Irkutsk Public will offset losses from the drop in Irkutsk Public's long position.
The idea behind Tarsus Pharmaceuticals and Irkutsk Public Joint pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Complementary Tools

Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance